Consistent with these results, pharmacological inhibition of the function of CD36, TLR2/6, or the coreceptors of CD36/TLR2/TLR6 abolished the enhanced capacities of BMDCs that were co‐cultured with the Arf1‐ablated tumor cells (Figure 5i,j). The gene discussed is TLR2; the disease is neoplasm.